The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Purpose of This PDQ Summary

Added this new section.

General Information

Added Strenger et al. as reference 34.

Treatment of High-Risk Neuroblastoma

Added text to state that a clinical trial is now being conducted on the use of topotecan and cyclophosphamide as initial induction chemotherapy.

Recurrent Neuroblastoma

Added text to state that the combination of cyclophosphamide and topotecan with or without etoposide has been used in recurrent disease (cited Simon et al. as reference 10).

Back to Top

< Previous Section  |  Next Section >